The vaccine will be given to individuals over the age of 60 and was 94 percent effective in preventing severe disease.
The vaccine could be available as soon as this fall, pending a recommendation for its use from the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, which will meet in June.
RSV can affect all age groups, but it is particularly worrisome in babies and older adults. It is a highly contagious virus that causes infections of the lungs and breathing passages., RSV leads to approximately 60,000 to 120,000 hospitalizations and 6,000 to 10,000 deaths among adults 65 years of age and older every year. It is also a common cause of lower respiratory tract disease in older adults. This disease affects the lungs and can cause life-threatening pneumonia and bronchiolitis.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
1st vaccine for RSV approved by FDAThe U.S. has approved the first vaccine for RSV, shots to protect older adults.
Baca lebih lajut »
FDA approves first vaccine for RSV after decades of attemptsThe U.S. approves the first vaccine for RSV, shots to protect older adults against a respiratory virus that’s most notorious for attacking babies but endangers their grandparents, too.
Baca lebih lajut »
World’s first RSV vaccine approved by FDA — breakthrough 60 years in the making“Our focus now is to ensure eligible older adults in the US can access the vaccine as quickly as possible,” said Tony Wood, the chief scientific officer at GSK.
Baca lebih lajut »
FDA Approves First Vaccine For RSVThe vaccine is the first to prevent lower respiratory tract disease caused by respiratory syncytial virus (RSV) for older adults ages 60 and older.
Baca lebih lajut »
FDA approves GSK's RSV vaccine for older adults, world's first shot against virusThe FDA's approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that targets respiratory syncytial virus to the market.
Baca lebih lajut »
First-ever RSV vaccine approved by FDA for adults 60 and overThe Food and Drug Administration (FDA) has approved the first respiratory syncytial virus (RSV) vaccine for use in the U.S., the public health agency announced on Wednesday.
Baca lebih lajut »